Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd M Morgan

Showing results (191-200 of 307) with videos related to

Pageof 31
Sort By:
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
Molecular Cancer Research : MCR|February 18, 2018
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic SignatureUdit Singhal, Yugang Wang, James Henderson, et al.
Clinical Genitourinary Cancer|June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate CancerTodd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
International Journal of Molecular Sciences|January 11, 2022
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Zachery R Reichert, Tadas Kasputis, Srinivas Nallandhighal, et al.
Urology|August 3, 2020
The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder CancerDeborah R Kaye, Christine Schafer, Steven Thelen-Perry, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2022
MyProstateScore in men considering repeat biopsy: validation of a simple testing approachJeffrey J Tosoian, Michael S Sessine, Bruce J Trock, et al.
The Journal of Urology|August 5, 2018
Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASSJames T Kearns, Anna V Faino, Jeanette M Schenk, et al.
Pageof 31

Showing results (191-200 of 307) with videos related to

Sort By:
Pageof 31
JAMA Oncology|August 28, 2020
Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk StabilityMatthew R Cooperberg, Yingye Zheng, Anna V Faino, et al.
Translational Oncology|March 29, 2020
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and InvasionYugang Wang, Udit Singhal, Yuanyuan Qiao, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
Molecular Cancer Research : MCR|February 18, 2018
Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic SignatureUdit Singhal, Yugang Wang, James Henderson, et al.
Clinical Genitourinary Cancer|June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate CancerTodd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
International Journal of Molecular Sciences|January 11, 2022
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Zachery R Reichert, Tadas Kasputis, Srinivas Nallandhighal, et al.
Urology|August 3, 2020
The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder CancerDeborah R Kaye, Christine Schafer, Steven Thelen-Perry, et al.
Prostate Cancer and Prostatic Diseases|December 30, 2022
MyProstateScore in men considering repeat biopsy: validation of a simple testing approachJeffrey J Tosoian, Michael S Sessine, Bruce J Trock, et al.
The Journal of Urology|August 5, 2018
Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASSJames T Kearns, Anna V Faino, Jeanette M Schenk, et al.
Pageof 31